Table of Contents

ANALGESIA AND DRUGS OF ABUSE

• You have access

  Dose-Response Analysis of Opioid Cross-Tolerance and Withdrawal Suppression During LAAM Maintenance

  Elisabeth J. Houtsmuller, Sharon L. Walsh, Kory J. Schuh, Rolley E. Johnson, Maxine L. Stitzer and George E. Bigelow

  Journal of Pharmacology and Experimental Therapeutics May 1998, 285 (2) 387-396;
• You have access

  Differentiation of Kappa Opioid Agonist-Induced Antinociception by Naltrexone Apparent pA₂ Analysis in Rhesus Monkeys ,

  Mei-Chuan Ko, Eduardo R. Butelman, John R. Traynor and James H. Woods

  Journal of Pharmacology and Experimental Therapeutics May 1998, 285 (2) 518-526;
• You have access

  S-(+)-3-Isobutylgaba and Its Stereoisomer Reduces the Amount of Inflammation and Hyperalgesia in an Acute Arthritis Model in the Rat

  Andrea K. Houghton, Ying Lu and Karin N. Westlund

  Journal of Pharmacology and Experimental Therapeutics May 1998, 285 (2) 533-538;
• You have access

  Evaluation of Cannabinoid Receptor Agonists and Antagonists Using the Guanosine-5′-O-(3-[³⁵S]thio)-triphosphate Binding Assay in Rat Cerebellar Membranes

  Graeme Griffin, Peter J. Atkinson, Vincent M. Showalter, Billy R. Martin and Mary E. Abood

  Journal of Pharmacology and Experimental Therapeutics May 1998, 285 (2) 553-560;
• You have access

  Kappa-Opioid Receptor Binding Populations in Rhesus Monkey Brain: Relationship to an Assay of Thermal Antinociception

  Eduardo R. Butelman, Mei-Chuan Ko, Katarzyna Sobczyk-Kojiro, Henry I. Mosberg, Barbara Van Bemmel, Gerald Zernig and James H. Woods

  Journal of Pharmacology and Experimental Therapeutics May 1998, 285 (2) 595-601;
• You have access

  Alterations in Corticotropin-Releasing Factor and Vasopressin Content in Rat Brain during Morphine Withdrawal: Correlation with Hypothalamic Noradrenergic Activity and Pituitary-Adrenal Response

  M.V. Milanés, M.L. Laorden, M. Chapleur-Château and A. Burlet

  Journal of Pharmacology and Experimental Therapeutics May 1998, 285 (2) 700-706;
• You have access

  Effects of Kappa-Opioid Receptor Agonists on Responses to Colorectal Distension in Rats with and without Acute Colonic Inflammation

  Maureen B. Burton and G. F. Gebhart

  Journal of Pharmacology and Experimental Therapeutics May 1998, 285 (2) 707-715;
• You have access

  ABT-594 [(R)-5-(2-Azetidinylmethoxy)-2-Chloropyridine]: A Novel, Orally Effective Analgesic Acting via Neuronal Nicotinic Acetylcholine Receptors: I. In VitroCharacterization

  Diana L. Donnelly-Roberts, Pamela S. Puttfarcken, Theresa A. Kuntzweiler, Clark A. Briggs, David J. Anderson, Jeffrey E. Campbell, Marietta Piattoni-Kaplan, David G. Mckenna, James T. Wasicak, Mark W. Holladay, Michael Williams and Stephen P. Arneric

  Journal of Pharmacology and Experimental Therapeutics May 1998, 285 (2) 777-786;
• You have access

  ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: A Novel, Orally Effective Antinociceptive Agent Acting viaNeuronal Nicotinic Acetylcholine Receptors: II. In VivoCharacterization

  Anthony W. Bannon, Michael W. Decker, Peter Curzon, Michael J. Buckley, David J. B. Kim, Richard J. Radek, John K. Lynch, James T. Wasicak, Nan-Horng Lin, William H. Arnold, Mark W. Holladay, Michael Williams and Stephen P. Arneric

  Journal of Pharmacology and Experimental Therapeutics May 1998, 285 (2) 787-794;
• You have access

  Cannabinoid-Precipitated Withdrawal: A Time-Course Study of the Behavioral Aspect and Its Correlation with Cannabinoid Receptors and G Protein Expression

  Tiziana Rubino, Gabriela Patrini, Paola Massi, Domenica Fuzio, Daniela Viganò, Gabriella Giagnoni and Daniela Parolaro

  Journal of Pharmacology and Experimental Therapeutics May 1998, 285 (2) 813-819;
• You have access

  Delta Opioid Receptor Subtypes Activate Inositol-Signaling Pathways in the Production of Antinociception

  Pilar Sánchez-Blázquez and Javier Garzón

  Journal of Pharmacology and Experimental Therapeutics May 1998, 285 (2) 820-827;